Raport privind investigaţia utilă pentru cunoaşterea pieţei distribuţiei ...

More documents

Recommendations

Info

21 SC Medimfarm SA 27,394 -1,775,677 -660,290 22 S&D Pharma Romania SRL 1,137,698 -1,964,432 -1,097,733 23 SC Valmedica SA 448,279 469,162 -1,815,073 24 SC Tamisa Trading SRL -2,117,658 -3,332,663 -2,940,104 25 SC Dornafarm SA 432399 9768 -5,920,240 26 SC Labormed Pharma Trading SRL -2,627,788 3,048,252 -10,603,536 27 SC Pharmafarm SA -11,484,515 -13,839,719 -12,879,483 28 S.C. Fildas Trading S.R.L. -20,933,727 -45,767,864 -15,867,895 29 SC Terapia Distribuţie SRL 54,519 1,299,376 -17,584,984 30 SC Relad International Pharma SRL -495,253 -39,040,438 -34,762,585 31 SC Montero SA 1,015,071 -13,465,184 -40,998,646
Programul de prevenire şi control al bolilor cu impact major asupra starii de sanatat a populatiei Programe nationale de sanatate de evaluare, profilactice si cu scop curativ finantate din Bugetul Fondului NAtional Unic de Asigurari de Sănătate 2007 1. Programul national de profilaxie 2. Programul national de sanatate mintala 3. Programul national de diabet si alte boli de nutritie 4. Programul national de transplant de organe, tesuturi si celule 5. Programul national de tratament în strainatate Necesar resurse: 6. Programul national de asistenta comunitara si actiuni pentru sanatate 7. Programul national al rezervei Ministerului Sanatatii Publice 8. Programul national privind evaluarea starii de sanatate a populatiei în asistenta medicala primara A. Programul national de sanatate cu scop curativ B. Programul national privind evaluarea starii de sanatate a populatiei în asistenta medicala primara 1.1. Subprogramul de sanatate publica Anexa nr. 9 1.2. Subprogramul privind bolile netransmisibile 1.3. Subprogramul de sanatate a femeii si copilului 2.1.Subprogramul de profilaxie în patologia psihiatrica si pshihosociala 2.2.Subprogramul tratamentul toxicodependentelor
Page 1 and 2:
Raport privind investigaţia utilă
Page 3 and 4:
ordin al ministrului sănătăţii
Page 5 and 6:
5.1. Relaţia producător- distribu
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
preţul de referinţă. Raport priv
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
naţionale de sănătate. Raport pr
Page 155 and 156: o valoare simbolică;[…] Raport p
Page 157 and 158: Raport privind investigaţia utilă
Page 187 and 188: Nr. crt. Grup Denumire producător
Page 189 and 190: Nr. crt. Denumire distribuitor 1 SC
Page 191 and 192: Nr. crt. Judeţ Denumire Spital 1 A
Page 193 and 194: 47 Covasna Spitalul de cardiologie
Page 195 and 196: 97 Suceava Spitalul Municipal Sfint
Page 197 and 198: 25 Nebilet Menarini C07AB12 inovati
Page 199 and 200: C10AA07 CRESTOR 10mg 28 C10AB05 LIP
Page 201 and 202: Anexa nr. 6 Nr. crt. Denumire distr
Page 203 and 204: Nr. crt An 2007 2008 2009 1 SC Roph
Page 205: Nr. crt An 2007 2008 2009 Anexa nr.
Page 209 and 210: Programe nationale de sanatate de e
Page 211 and 212: Programe nationale de sanatate de e
Page 213 and 214: 1. Precizaţi ce tipuri de activit
Page 215 and 216: 17. În general, lista de produse c
Page 217 and 218: 1. Precizaţi ce tipuri de activit
Page 219 and 220: Piaţa ATC 4 Nr. producători Cel m
Page 221 and 222: Nr. crt. Piata ATC 4 Valoare vanză
Page 223 and 224: 20 J J01DC 67,750,309 Cefuroxim a 7
Page 225 and 226: 44 L L01CA 11,951,190 Sindovin 1g 4
Page 227: 70 N N02BA 42,760,562 71 N N02BA 42
show all

Raport privind investigaţia utilă pentru cunoaşterea pieţei distribuţiei ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?